ISPOR Europe 2022 Plenaries and Speakers Announced

Published Oct 4, 2022

Conference Will Be Held 6-9 November in Vienna, Austria

ISPOR Europe 2022Lawrenceville, NJ, USA—October 4, 2022—ISPOR—The Professional Society for Health Economics and Outcomes Research announced today its plenary sessions and speakers for its ISPOR Europe 2022 conference. The conference will be held 6-9 November in Vienna, Austria and focused on the theme, “Collaborating Across Borders: Building and Using Evidence to Enable Access.” The conference theme is especially timely, as the new Health Technology Assessment (HTA) Regulation in the European Union has spurred conversations about how different countries, regions, or even cities, can work together in a variety of outcomes research methods. Conference registration options include in-person as well as virtual attendance.

Plenary sessions and speakers for the conference are outlined below. Speakers listed are confirmed with additional speakers added to the online program as they are confirmed.

Plenary 1—Monday, 7 November:
The Convergence of HTA and Regulation: A New HTA Reality and Collaboration with Regulatory Agencies
The new HTA regulation in Europe is expected to have a more systematic and synergic collaboration with regulatory agencies. This session will explore how the different activities and remits of both regulatory and HTA assessment can be optimized. Confirmed speakers currently include:

  • Moderator: Rui Santos Ivo; INFARMED; Lisbon, Portugal
  • Marcus Guardian, MBA; EUnetHTA; Diemen, Netherlands

     

    Plenary 2—Tuesday, 8 November:
    Patient-Centered Research in the Real World: Possible Across Borders?
    This session will discuss advances and lessons learned for reliably capturing patient-centric data and whether doing so across borders is realistic to aid in effectiveness evaluation of new medicines. Confirmed speakers currently include:

  • Moderator: Tara Symonds, PhD; Clinical Outcomes Solutions Ltd; Folkestone, England, UK
  • Nancy Devlin, PhD; University of Melbourne; Melbourne, Australia
  • Eleanor M. Perfetto, PhD, RPh, MS; University of Maryland; Baltimore, MD, USA

     

    Plenary 3—Wednesday, 9 November:
    Innovative Methods for Integrating Data Across Outcomes and Borders
    The volume, granularity, and heterogeneity of real-world evidence have been growing exponentially as technology platforms provided new opportunities to access, link, and integrate these data and use them for outcomes research and regulatory purposes. This session will examine innovative study designs to derive comparative effectiveness when randomized controlled trials cannot be performed. Confirmed speakers currently include:

  • Moderator: Uwe Siebert, MD, MPH, MSc, ScD; UMIT - University for Health Sciences; Hall in Tirol, Austria
  • Peter Arlett, MBBS (MD); European Medicines Agency; Amsterdam, Netherlands

The ISPOR Short Course Program for HEOR training and education will also be offered on 6 November at ISPOR Europe 2022.

ISPOR is recognized globally as the leading professional society for health economics and outcomes research and for its role in improving healthcare decisions. ISPOR Europe 2022 draws healthcare stakeholders with an interest in HEOR, including researchers and academicians, assessors and regulators, payers and policymakers, the life sciences industry, healthcare providers, and patient engagement organizations.

Additional information on the conference can be found at:
Conference Information  |  Program  | Short Courses  |  Press  |  Exhibits & Sponsorship

###

ABOUT ISPOR
ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Website  | LinkedIn  | Twitter (@ispororg)  |  YouTube  |  Facebook  |  Instagram 

Related Stories

ISPOR Task Force Addresses Critical Gap in Surrogate Endpoint Guidance

May 28, 2026

Value in Health, announced the publication of an ISPOR Good Practices Report providing guidance on the use of surrogate endpoint evaluation methods in health technology assessment (HTA) decision making. The report, “Methods for Evaluation of Surrogate Endpoints for HTA Decision Making: A Good Practices Report of an ISPOR Task Force,” was published in the May 2026 issue of Value in Health.

How Is Health Valued in the United Kingdom? We Finally Have a Better Answer

May 27, 2026

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a pair of companion articles that together establish both the methodological foundation of the first definitive UK value set for the EQ-5D-5L and the practical implications of adopting it—thus equipping health technology assessment decision makers with a UK value set suitable for informing policy. The articles were featured in the May 2026 issue of Value in Health.

ISPOR Announces 2026-2027 Board of Directors

May 26, 2026

ISPOR—The Professional Society for Health Economics and Outcomes Research announced its 2026-2027 board of directors who will assume office on July 1, 2026.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×